openPR Logo
Press release

Kidney Disease Market Poised to Hit $149.44 Billion by 2029 with Accelerating Growth Trends

07-11-2025 07:52 AM CET | Health & Medicine

Press release from: The Business Research Company

Kidney Disease

Kidney Disease

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Kidney Disease Market Size Growth Forecast: What to Expect by 2025?
The market size for kidney disease has seen significant expansion in the past few years. It is projected to expand from $107.29 billion in 2024 to $114.74 billion in 2025, marking a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth over the historic period includes the increase in chronic health issues, an aging demographic, susceptibility due to genetics, advancement in medical research and education, and environmental elements.

How Will the Kidney Disease Market Size Evolve and Grow by 2029?
The market size for kidney disease is projected to witness substantial expansion in the forthcoming years, reaching a value of $149.44 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. The growth anticipated in this duration can be credited to the management of infectious diseases worldwide, the introduction of precision medicine techniques, the rise of diabetes and obesity, shifts in healthcare policies, and increased awareness and screening. Key trends to watch for in the forecast period comprise kidney care via telemedicine, emphasis on preventive nephrology, the surge in home-based dialysis, evolution of regenerative therapies, and alterations in diet and nutrition.

View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

What Drivers Are Propelling the Growth of Kidney Disease Market Forward?
The surge in kidney ailment cases is predicted to drive the expansion of the kidney disease market. Kidney diseases encompass a plethora of conditions that impinge on the kidneys' functionality and structure. Medications for kidney disorders administer functions such as reducing blood pressure in patients and minimizing protein loss. They consequently slow down kidney damage, manage symptoms, and prevent further complexities. For example, in June 2023, Kidney Research UK - a charitable organization based in the UK that focuses on research and advocacy for enhanced understanding, prevention, and treatment of kidney diseases - estimated that about 7.19 million people in the UK were suffering from chronic kidney disease. This represented more than 10% of the UK's population and is projected to rise to 7.61 million people by 2033. Hence, the escalating incidence of kidney ailments is spurring growth in the kidney disease market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

Which Emerging Trends Are Transforming the Kidney Disease Market in 2025?
The incorporation of tools powered by artificial intelligence (AI) is an evolving trend in the kidney disease market. Enterprises in this sector are leveraging cutting-edge technologies to enhance patient results and maintain their market prominence. For instance, an AI-focused healthcare startup based in the USA, Carenostics, introduced their pioneering product in November 2022. This product is designed to review electronic health record (EHR) data for the early detection of chronic kidney disease (CKD). Carenostics has adeptly incorporated AI-fueled clinical decision-support models into EHR systems utilized by healthcare providers. This integration assists healthcare practitioners in accurately identifying patients at high risk of chronic diseases, allowing them to take preemptive steps towards improved patient care.

What Are the Key Segments in the Kidney Disease Market?
The kidney disease market covered in this report is segmented -

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:
1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants
2) By Dialysis: Hemodialysis, Peritoneal Dialysis
3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

Who Are the Key Players Shaping the Kidney Disease Market's Competitive Landscape?
Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.

What Geographic Markets Are Powering Growth in the Kidney Disease Market?
North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kidney Disease Market Poised to Hit $149.44 Billion by 2029 with Accelerating Growth Trends here

News-ID: 4100381 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Kidney

Chronic Kidney Diseases Fueling Kidney Stone Retrieval Device Growth Driving Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Kidney Stone Retrieval Devices Market Size By 2025? In recent times, the market size for kidney stone retrieval devices has seen consistent growth. The market, which is projected to increase from $2.84 billion in 2024 to $2.96 billion in 2025, forecasts a compound annual growth
Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook: The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview: Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029. The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for